Invibio
Invibio supplies implant-grade PEEK polymers and biomaterial solutions (notably PEEK-OPTIMA) to medical device manufacturers for use in spine, orthopedic, trauma, and other implantable devices, operating as the medical division of Victrex plc with a B2B enterprise sales model.
- Company typePrivate
- Founded1999
- HeadquartersLancaster, United Kingdom
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Invibio does
Invibio Limited is a UK-based subsidiary of Victrex plc (LSE: VCT) that supplies implant-grade PEEK polymers and biomaterial solutions to medical device manufacturers worldwide. The company was formed in the 1990s and introduced PEEK-OPTIMA in 1999 as the world's first implantable PEEK polymer; PEEK-OPTIMA has since been used in over 15 million implanted devices with zero material-related recalls. Its portfolio includes PEEK-OPTIMA base grades, PEEK-OPTIMA HA Enhanced (hydroxyapatite-blended for bone ongrowth), PEEK-CLASSIX (non-implantable medical grade), PEEK-OPTIMA AM filament for additive manufacturing (launched March 2023), and VICTREX PC for pharmaceutical contact applications. The business operates a B2B enterprise go-to-market, selling materials under qualification-and-supply agreements to spine, orthopedics, trauma, and broader medical device OEMs, while layering technical, regulatory, and development services on top via the Leeds product development and manufacturing centre (opened 2023) and an Innovation Partnership Program. Customer concentration is distributed across multiple enterprise OEMs (NG Medical, Omnia Medical, Spinal Elements, Maxx Orthopedics, In2Bones, Nvision, Weigao, Beijing Fule, Double Medical), supplemented by surgeon engagement through a Surgeon Education Network. Direct revenue figures are not publicly broken out; pricing is quote-based and undisclosed, and the model combines one-time material sale transactions with embedded technical and regulatory service revenue.
Invibio firmographics
Firmographics- Name
- Invibio
- Legal name
- Invibio Limited
- Website
- https://invibio.com
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Invibio supplies implant-grade PEEK polymers and biomaterial solutions (notably PEEK-OPTIMA) to medical device manufacturers for use in spine, orthopedic, trauma, and other implantable devices, operating as the medical division of Victrex plc with a B2B enterprise sales model.
- Ownership category
- akta.pro rank
Invibio industry classification
Industry- Product category
- Medical Biomaterials (Implantable PEEK Polymers)
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB)
- akta.pro secondary industries
- 3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial) (HLAHAEAJ), Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA), Medical & Dental Prototyping (Models, Guides, Pre-Op Planning) (IMAAAFAI)
Keywords
Where Invibio is headquartered
LocationHeadquarters
- HQ city
- Lancaster
- HQ country
- United Kingdom
- HQ region
- Europe
Offices2 records
Markets served
Invibio business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Operations, Supply Chain, Personnel, Marketing or Sales
Revenue model
- PEEK Polymer Materials Sales: Invibio generates revenue through the sale of implant-grade PEEK polymer materials (PEEK-OPTIMA, PEEK-CLASSIX) to medical device manufacturers for use in spinal, orthopedic, trauma, and other medical implants.
- Technical and Regulatory Support Services: Revenue generated from providing technical expertise, regulatory support, testing, validation, and scale-up services to medical device companies throughout the product development and commercialization process.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
Invibio product offering
Product offeringCore offering
Invibio manufactures and supplies implant-grade PEEK polymers and biomaterial solutions to medical device companies. Its core product family, PEEK-OPTIMA, includes standard implantable grades, hydroxyapatite-enhanced (HA Enhanced) grades for bone ongrowth, AM filament for 3D printing of patient-specific implants, PEEK-CLASSIX for non-implantable medical device components, and VICTREX PC pharmaceutical-contact grades. The portfolio supports spinal cages, trauma fixation, knee arthroplasty, active implants, and drug delivery applications, paired with regulatory and technical support services.
Product overview
Invibio is a leading provider of implant-grade PEEK polymers and biomaterial solutions for medical device manufacturers. The company's core product is PEEK-OPTIMA, the world's first implantable PEEK polymer, offered alongside variants like PEEK-OPTIMA HA Enhanced (hydroxyapatite-enhanced for bone ongrowth) and PEEK-CLASSIX for non-implantable applications. Invibio provides specialized solutions including additive manufacturing filaments (PEEK-OPTIMA AM), composite trauma plates, knee replacement components, and pharmaceutical contact grades (VICTREX PC). The portfolio serves application areas spanning spine & orthopedics (spinal cages, hip & knee, sports medicine), trauma (CMF, foot & ankle, fracture fixation), and medical devices (active implants, drug delivery). The company supports medical device companies from concept to commercialisation through materials, regulatory support, and technical expertise.
Differentiator
Problem solved
Functional benefit
Brands
- PEEK-OPTIMA™: World's first implantable PEEK polymer with over 20 years of proven clinical history and zero material-related recalls.
- PEEK-OPTIMA AM
Products and services
- PEEK-OPTIMA Polymers Implantable-grade PEEK polymer with over 20 years of clinical history and zero material-related recalls. Used in spinal cages, hip & knee implants, trauma devices, and other implantable medical devices. Designed for medical device manufacturers seeking biocompatible, radiolucent, bone-like modulus materials cleared under FDA 510(k), CE Mark, and MDR pathways.
- PEEK-OPTIMA HA Enhanced Hydroxyapatite-enhanced PEEK polymer grade that supports bone ongrowth across the entire implant surface, combining the osseo-integrative benefits of titanium with PEEK's radiolucency and bone-like modulus. For medical device manufacturers developing implants requiring enhanced bone bonding.
- PEEK-OPTIMA AM Filament Implantable PEEK filament specifically designed for 3D printing of medical implants, enabling patient-specific and complex-geometry implantable devices through additive manufacturing. For medical device manufacturers seeking to produce custom or geometrically complex implants.
- PEEK-CLASSIX PEEK polymer grades for medical device manufacturing applications, providing biocompatible PEEK options for non-implantable medical device components.
- VICTREX PC (Pharmaceutical Contact Grade PEEK) PEEK polymer specifically developed for pharmaceutical-contact applications, enabling use in drug delivery devices requiring regulatory compliance for pharmaceutical contact materials.
- Composite Trauma Plates PEEK-based composite materials developed for trauma repair and reconstruction, enabling lighter, more flexible devices that maintain high strength and imaging compatibility for fracture fixation applications. For medical device manufacturers producing trauma, CMF, and extremity reconstruction devices.
- Knee Replacement Solutions PEEK-OPTIMA polymer femoral components and related materials for total knee arthroplasty, offering an alternative to metal with bone-like modulus and MRI compatibility. For orthopedic device manufacturers developing knee replacement systems.
Quantifiable outcome
- Zero material-related recalls across all applications in 20+ years
- +1 more outcomes
Companies that use Invibio
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles3 records
Invibio technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Invibio partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered minor and core.
- Paragon MedicalminorNew collaboration announced in 2023 for medical device development partnership.
- Beijing FulecoreCooperation leading to the first POHAE (PEEK-OPTIMA HA Enhanced) cage in China, marking a significant milestone for PEEK-based implants in the Chinese market.
- In2BonesminorCollaboration for extremity reconstruction devices using PEEK biomaterials.
- NvisionminorFDA clearance obtained for osteotomy wedge system using Invibio's PEEK materials.
- Double MedicalcorePartnership to drive implantable devices using PEEK-OPTIMA into the China market, leveraging Double Medical's local distribution capabilities.
- CarbofixminorPartnership with UK Olympic sprinter James Ellington on new passion project, demonstrating Carbofix's orthopedic devices.
- Maxx OrthopedicscoreCollaboration on knee-replacement technology using PEEK-OPTIMA polymers, including joint development and US IDE approval for PEEK-OPTIMA Total Knee Arthroplasty Study in 2024.
- WeigaocoreCollaboration with China's Weigao on spinal implant development and market introduction, leveraging local market expertise with Invibio's biomaterial technology.
- VictrexcoreVictrex is the parent company of Invibio, providing world-class manufacturing and supply chain capabilities. Invibio leverages Victrex's polymer expertise and global supply chain for consistent material availability and quality assurance.
Scale indicators4 records
Recent moves7 records
Expansion highlights6 records
Invibio competitors and assessment
Company assessmentDirect peers
- Syensqo (formerly Solvay Specialty): Syensqo is a specialty materials company producing high-performance polymers including medical-grade PEEK for implantable devices. As a direct competitor in the medical polymer materials space, it shares Invibio's customer base of spine and orthopedic device manufacturers.
- Solvay (medical-grade PEEK/chemicals): Solvay supplies high-performance specialty polymers including medical-grade offerings that compete with Invibio's PEEK portfolio in implantable and medical device markets. As a large diversified chemical manufacturer, it competes on scale, regulatory support, and downstream polymer customization.
- Evonik Industries (VESTAKEEP): Evonik produces VESTAKEEP implantable-grade PEEK polymers, serving medical device manufacturers with biomaterials analogous to Invibio's PEEK-OPTIMA. Both compete directly as implant-grade PEEK suppliers to spine and orthopedic OEMs, with comparable regulatory clearances and device integration targets.
- DSM Biomedical (a dsm-firmenich company): DSM Biomedical supplies biomaterials and medical device materials—including polymers used in implantables—to medical device OEMs, directly competing with Invibio on biomaterial solutions across spine, orthopedics, and cardiovascular device applications.
Emerging players
- EOS GmbH (additive manufacturing for medical): EOS supplies industrial 3D printing systems, including polymer printing platforms used for medical implant production. As an AM hardware partner ecosystem for Invibio's PEEK-OPTIMA AM filament, it represents both an enabling technology layer and competitive 3D-printed implant pathway.
- Carbofix Orthopedics: Carbofix develops carbon fiber-reinforced PEEK composite orthopedic devices and is a partner/customer of Invibio. As a device OEM, it represents the downstream use case of Invibio's polymer materials in trauma and spine applications.
- 3D Systems (medical 3D printing): 3D Systems provides healthcare 3D printing solutions including patient-specific implants and surgical planning. Its implant offerings create both a complementary ecosystem for Invibio's PEEK-OPTIMA AM filament and a competing patient-specific implant modality.
- Maxx Orthopedics: Maxx Orthopedics is the development partner with Invibio on the PEEK-OPTIMA Total Knee Arthroplasty program with FDA IDE approval. It represents a key downstream commercialization channel and use-case validator for Invibio's biomaterial innovation in joint reconstruction.
Broad incumbents
- Mitsubishi Chemical Group (medical polymers): Mitsubishi Chemical supplies engineering plastics including high-performance polymers used in medical device applications. While broader in portfolio, its medical polymer offerings overlap with Invibio's PEEK solutions for implantable and surgical device manufacturers.
- Victrex plc: Invibio's parent company and the original inventor of PEEK polymer with integrated monomer-to-polymer manufacturing. Victrex supplies the same PEEK polymer feedstock that Invibio qualifies for medical use, making it the closest comparator on underlying chemistry and supply chain scale.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat7 records
Key risks5 records
Key highlights7 records
Customer concentration
Invibio social profiles
Digital presenceInvibio compliance and trust
Trust signalCompliance5 records
Invibio financial estimates
Financial estimateRevenue estimate
Valuation estimate
Invibio leadership team
Management profileNumber of profiles
Invibio funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Invibio M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Invibio
What does Invibio do?
Invibio manufactures and supplies implant-grade PEEK polymers and biomaterial solutions to medical device companies. Its core product family, PEEK-OPTIMA, includes standard implantable grades, hydroxyapatite-enhanced (HA Enhanced) grades for bone ongrowth, AM filament for 3D printing of patient-specific implants, PEEK-CLASSIX for non-implantable medical device components, and VICTREX PC pharmaceutical-contact grades. The portfolio supports spinal cages, trauma fixation, knee arthroplasty, active implants, and drug delivery applications, paired with regulatory and technical support services.
Is Invibio a public or private company?
Invibio is a private company. It is classified as corporate owned and is currently operating.
When was Invibio founded?
Invibio was founded in 1999. It employs 101 to 250 people.
Where is Invibio based?
Invibio is headquartered in Lancaster, United Kingdom, in the Europe region.
How does Invibio make money?
Two revenue lines are on record. PEEK Polymer Materials Sales are the primary driver. The others are technical and Regulatory Support Services.
Who are Invibio's main competitors?
Direct peers on record are Syensqo (formerly Solvay Specialty), Solvay (medical-grade PEEK/chemicals), Evonik Industries (VESTAKEEP) and DSM Biomedical (a dsm-firmenich company). Emerging players are EOS GmbH (additive manufacturing for medical), Carbofix Orthopedics, 3D Systems (medical 3D printing) and Maxx Orthopedics. Broad incumbents are Mitsubishi Chemical Group (medical polymers) and Victrex plc.
Does Invibio have an API?
No public API is recorded for Invibio.
What industry is Invibio in?
Invibio's product category is Medical Biomaterials (Implantable PEEK Polymers). Its primary akta.pro industry code is HLAHAEAB, Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation), with a secondary code of HLAHAEAJ, 3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial). Its NAICS code is 339113 and its SIC code is 3842.